Brief: Medipharm Labs Expands CBN Portfolio With Two New Products
23/11/2021 12:27
Nov 23 (Reuters) - Medipharm Labs Corp LABS.TO :
* MEDIPHARM LABS EXPANDS CBN PORTFOLIO WITH TWO NEW PRODUCTS
* MEDIPHARM LABS CORP - NEW CBN PRODUCTS INCLUDE CBN:CBD 1:2
RELAX
FORMULA OIL AND A NORTHBOUND HIGH CBN AND HIGH CBD VAPE
CARTRIDGE
Source text for Eikon: ID:nGNX93fHkC
Further company coverage: LABS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medipharm Labs
See all newsCanada's MediPharm Labs Q2 revenue rises 11% on international growth
Brief: MediPharm Labs Q2 Revenue CAD 10 Million
Canada's MediPharm Labs reports positive Q1 adjusted EBITDA
Canada's MediPharm Labs FY revenue rises 8% on international sales
Brief: Medipharm Labs Reports Full Year & Fourth Quarter 2025 Results With Over 40% Annual Growth In International Medical Revenue